# Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous

> **NCT03042260** · PHASE4 · UNKNOWN · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 310 (estimated)

## Conditions studied

- Lupus Erythematosus, Systemic

## Interventions

- **DRUG:** Trimethoprim-Sulfamethoxazole
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03042260
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-01
- **Primary completion:** 2021-02
- **Final completion:** 2021-08
- **Target enrollment:** 310 (ESTIMATED)
- **Last updated:** 2019-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03042260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03042260, "Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03042260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*